NO972642L - Fremgangsmåte for fremstilling av en proteinanalog til Bordetella-eksotoksin - Google Patents

Fremgangsmåte for fremstilling av en proteinanalog til Bordetella-eksotoksin

Info

Publication number: NO972642L
Authority: NO; Norway
Prior art keywords: preparing; subunits; protein analog; bordetella exotoxin; retain
Prior art date: 1987-09-04

Application number

NO972642A

Other languages

English (en)

Other versions

NO972642D0 (no

NO325016B1 (no

Inventor

Iii Walter Neal Burnette

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-04

Filing date

1997-06-09

Publication date

1997-07-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26788722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO972642(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-06-09 Application filed by Amgen Inc filed Critical Amgen Inc

1997-06-09 Publication of NO972642D0 publication Critical patent/NO972642D0/no

1997-07-28 Publication of NO972642L publication Critical patent/NO972642L/no

2008-01-14 Publication of NO325016B1 publication Critical patent/NO325016B1/no

Links

OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 title abstract 2
241000588807 Bordetella Species 0.000 title abstract 2
231100000776 exotoxin Toxicity 0.000 title abstract 2
239000002095 exotoxin Substances 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
108020004511 Recombinant DNA Proteins 0.000 abstract 1
230000004071 biological effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002255 enzymatic effect Effects 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000012986 modification Methods 0.000 abstract 1
230000004048 modification Effects 0.000 abstract 1
239000003053 toxin Substances 0.000 abstract 1
231100000765 toxin Toxicity 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)

NO19972642A 1987-09-04 1997-06-09 Fremgangsmate for fremstilling av en proteinanalog til Bordetella-eksotoksin, polypeptidanalog av S1-subenhet fra Bordetella pertussis-toksin og vaksine mot pertussis. NO325016B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US9430787A	1987-09-04	1987-09-04
US23248288A	1988-08-17	1988-08-17
PCT/US1988/002983 WO1989001976A1 (en)	1987-09-04	1988-08-26	Recombinant dna-derived bordetella toxin subunit analogs

Publications (3)

Publication Number	Publication Date
NO972642D0 NO972642D0 (no)	1997-06-09
NO972642L true NO972642L (no)	1997-07-28
NO325016B1 NO325016B1 (no)	2008-01-14

Family

ID=26788722

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO891842A NO301844B1 (no)	1987-09-04	1989-05-03	DNA-molekyl som koder for en polypeptidanalog til S1-underenheten i Bordetella-eksotoksin, og fremgangsmåte for fremstilling av en proteinanalog til S1-underenheten i Bordetella-eksotoksin
NO19972642A NO325016B1 (no)	1987-09-04	1997-06-09	Fremgangsmate for fremstilling av en proteinanalog til Bordetella-eksotoksin, polypeptidanalog av S1-subenhet fra Bordetella pertussis-toksin og vaksine mot pertussis.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO891842A NO301844B1 (no)	1987-09-04	1989-05-03	DNA-molekyl som koder for en polypeptidanalog til S1-underenheten i Bordetella-eksotoksin, og fremgangsmåte for fremstilling av en proteinanalog til S1-underenheten i Bordetella-eksotoksin

Country Status (16)

Country	Link
US (1)	US5773600A (no)
EP (2)	EP0629696A1 (no)
JP (1)	JP2918895B2 (no)
KR (1)	KR0168039B1 (no)
CN (1)	CN1033866C (no)
AT (1)	ATE125568T1 (no)
CA (1)	CA1341560C (no)
DE (1)	DE3854213T3 (no)
DK (1)	DK175821B1 (no)
ES (1)	ES2076160T5 (no)
FI (1)	FI101632B (no)
GR (1)	GR3017497T3 (no)
IE (1)	IE69753B1 (no)
IL (3)	IL87608A0 (no)
NO (2)	NO301844B1 (no)
WO (1)	WO1989001976A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6713072B1 (en) *	1987-11-02	2004-03-30	Chiron S.R.L.	Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
US5925546A (en) *	1987-11-02	1999-07-20	Chiron S.P.A.	Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
IT1223334B (it) *	1987-11-02	1990-09-19	Sclavo Spa	Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
US5332583A (en) *	1987-11-24	1994-07-26	Connaught Laboratories Limited	Vaccine containing genetically-detoxified pertussis holotoxin
GB8727489D0 (en) *	1987-11-24	1987-12-23	Connaught Lab	Detoxification of pertussis toxin
US5358868A (en) *	1987-11-24	1994-10-25	Connaught Laboratories Limited	Genetic detoxification of pertussis toxin
US7232671B2 (en) *	1989-02-15	2007-06-19	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Pertussis toxin gene: cloning and expression of protective antigen
CA2009991A1 (en) *	1989-02-15	1990-08-15	Witold Cieplak	Pertussis toxin gene: cloning and expression of protective antigen
ATE127347T1 (de) *	1989-04-28	1995-09-15	Sclavo Spa	Pertussistoxin-mutanten, dieselbe produzierende bordetella-stämme und ihre verwendung als vakzin gegen pertussis.
US5786189A (en) *	1989-11-29	1998-07-28	Smithkline Beecham Biologicals (S.A.)	Vaccine
GB9326174D0 (en) *	1993-12-22	1994-02-23	Biocine Sclavo	Mucosal adjuvant
US20030072774A1 (en) *	1994-06-10	2003-04-17	Diane M. Gajewczyk	Proteinaceous adjuvants
CA2220048C (en) *	1995-05-04	2006-03-07	Connaught Laboratories Limited	Acellular pertussis vaccines and methods of preparation thereof
WO1997043407A1 (en) *	1996-05-10	1997-11-20	Phylomed Corporation	Methods for oxidizing disulfide bonds using ozone
FR2754543B1 (fr) *	1996-10-11	1998-12-31	Pasteur Institut	Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US6818222B1 (en)	1997-03-21	2004-11-16	Chiron Corporation	Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US9453251B2 (en)	2002-10-08	2016-09-27	Pfenex Inc.	Expression of mammalian proteins in Pseudomonas fluorescens
GB0313916D0 (en)	2003-06-16	2003-07-23	Glaxosmithkline Biolog Sa	Vaccine composition
CN101031655A (zh)	2004-07-26	2007-09-05	陶氏环球技术公司	通过株工程改进蛋白表达的方法
CA2590906C (en) *	2004-12-17	2017-01-03	Nvi Nederlands Vaccininstituut	Deacylation of lps in gram negative bacteria
CA2685326A1 (en)	2007-04-27	2008-11-06	Dow Global Technologies Inc.	Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en)	2007-04-27	2017-02-28	Pfenex, Inc.	Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
ITMI20090946A1 (it)	2009-05-28	2010-11-29	Novartis Ag	Espressione di proteine ricombinanti
WO2011126811A2 (en)	2010-03-30	2011-10-13	Pfenex Inc.	High level expression of recombinant toxin proteins
US9169304B2 (en)	2012-05-01	2015-10-27	Pfenex Inc.	Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US20140037680A1 (en)	2012-08-06	2014-02-06	Glaxosmithkline Biologicals, S.A.	Novel method
WO2014024026A1 (en)	2012-08-06	2014-02-13	Glaxosmithkline Biologicals S.A.	Method for eliciting in infants an immune response against rsv and b. pertussis
KR102236498B1 (ko)	2013-03-08	2021-04-06	얀센 백신스 앤드 프리벤션 비.브이.	무세포 백일해 백신
MX2016001695A (es)	2013-08-05	2016-05-02	Glaxosmithkline Biolog Sa	Composiciones inmunogenas de combinacion.
CN109172818B (zh) *	2018-08-02	2021-10-22	浙江康佰裕生物科技有限公司	一种蛋白牛痘疫苗及其效力检测方法
CA3115085A1 (en) *	2018-10-15	2020-04-23	Arizona Board Of Regents On Behalf Of The University Of Arizona	Vaccine polypeptide compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4704362A (en) *	1977-11-08	1987-11-03	Genentech, Inc.	Recombinant cloning vehicle microbial polypeptide expression
FR2590483B1 (fr) *	1985-11-22	1988-12-09	Pasteur Institut	Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) *	1986-01-28	1999-02-02	Rino Rappuoli	Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
EP0275689B1 (en) *	1986-12-23	1992-09-02	The Board Of Trustees Of The Leland Stanford Junior University	Modified pertussis exotoxin
IT1223334B (it) *	1987-11-02	1990-09-19	Sclavo Spa	Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
GB8727489D0 (en) *	1987-11-24	1987-12-23	Connaught Lab	Detoxification of pertussis toxin
IT1223529B (it) *	1987-12-18	1990-09-19	Sclavo Spa	Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse

1988
- 1988-08-26 JP JP63507460A patent/JP2918895B2/ja not_active Expired - Lifetime
- 1988-08-26 KR KR1019890700803A patent/KR0168039B1/ko not_active IP Right Cessation
- 1988-08-26 WO PCT/US1988/002983 patent/WO1989001976A1/en active IP Right Grant
- 1988-08-30 IL IL87608A patent/IL87608A0/xx not_active IP Right Cessation
- 1988-08-30 IL IL10312188A patent/IL103121A/en not_active IP Right Cessation
- 1988-09-01 EP EP94109317A patent/EP0629696A1/en not_active Withdrawn
- 1988-09-01 AT AT88308124T patent/ATE125568T1/de not_active IP Right Cessation
- 1988-09-01 DE DE3854213T patent/DE3854213T3/de not_active Expired - Lifetime
- 1988-09-01 ES ES88308124T patent/ES2076160T5/es not_active Expired - Lifetime
- 1988-09-01 EP EP88308124A patent/EP0306318B2/en not_active Expired - Lifetime
- 1988-09-02 IE IE266888A patent/IE69753B1/en not_active IP Right Cessation
- 1988-09-02 CA CA 576469 patent/CA1341560C/en not_active Expired - Fee Related
- 1988-09-05 CN CN88107056A patent/CN1033866C/zh not_active Expired - Lifetime
1989
- 1989-05-03 FI FI892131A patent/FI101632B/fi not_active IP Right Cessation
- 1989-05-03 NO NO891842A patent/NO301844B1/no not_active IP Right Cessation
- 1989-05-03 DK DK198902162A patent/DK175821B1/da active
1992
- 1992-09-09 IL IL103121A patent/IL103121A0/xx unknown
1995
- 1995-06-06 US US08/468,679 patent/US5773600A/en not_active Expired - Lifetime
- 1995-09-21 GR GR950402614T patent/GR3017497T3/el unknown
1997
- 1997-06-09 NO NO19972642A patent/NO325016B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE3854213T2 (de)	1995-12-07
CA1341560C (en)	2007-10-30
FI892131A0 (fi)	1989-05-03
KR0168039B1 (ko)	1999-01-15
NO301844B1 (no)	1997-12-15
NO891842D0 (no)	1989-05-03
JPH04501051A (ja)	1992-02-27
NO891842L (no)	1989-06-21
EP0629696A1 (en)	1994-12-21
IE882668L (en)	1989-03-04
FI101632B1 (fi)	1998-07-31
DK216289A (da)	1989-06-30
IL87608A0 (en)	1989-01-31
ES2076160T5 (es)	2004-12-01
GR3017497T3 (en)	1995-12-31
ES2076160T3 (es)	1995-11-01
ATE125568T1 (de)	1995-08-15
AU623867B2 (en)	1992-05-28
FI101632B (fi)	1998-07-31
AU2386488A (en)	1989-03-31
DE3854213T3 (de)	2004-10-21
NO972642D0 (no)	1997-06-09
DK175821B1 (da)	2005-03-14
DE3854213D1 (de)	1995-08-31
US5773600A (en)	1998-06-30
NO325016B1 (no)	2008-01-14
CN1033866C (zh)	1997-01-22
KR890701758A (ko)	1989-12-21
DK216289D0 (da)	1989-05-03
EP0306318A1 (en)	1989-03-08
FI892131A (fi)	1989-05-03
EP0306318B2 (en)	2004-04-28
EP0306318B1 (en)	1995-07-26
WO1989001976A1 (en)	1989-03-09
CN1033072A (zh)	1989-05-24
JP2918895B2 (ja)	1999-07-12
IE69753B1 (en)	1996-10-02
IL103121A (en)	1995-08-31
IL103121A0 (en)	1993-02-21

Publication	Publication Date	Title
NO972642D0 (no)	1997-06-09	Fremgangsmåte for fremstilling av en proteinanalog til Bordetella-eksotoksin
KR100594787B1 (ko)	2006-07-03	경구용 백신 및 치료제의 전신 전달용 조성물 및 방법
ES2156110T3 (es)	2001-06-16	Analogos de sub-unidades de toxina del colera derivados de adn recombinante.
NO164177C (no)	1990-09-12	Rekombinant dna-fremgangsmaate for fremstilling av et polypeptid med funksjon av human immun (gamma)-interferon.
MX9203458A (es)	1992-09-01	Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
ATE127345T1 (de)	1995-09-15	Stressproteine und verwendungen dafür.
CA2231603A1 (en)	1997-04-24	Chicken interleukin-15 and uses thereof
ATE268384T1 (de)	2004-06-15	Analog von haemophilus hin47 mit verminderter protease aktivität
ATE157258T1 (de)	1997-09-15	Zubereitungen und behandlungen von pneumonia in tieren
HK51597A (en)	1997-04-25	Vaccines for human respiratory virus
MY101874A (en)	1992-01-31	Vaccine
DK0563254T3 (da)	1996-02-12	Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
NZ224251A (en)	1991-09-25	Synthetic rhinovirus (hrv) peptides and vaccines
Petersen et al.	1993	Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin
BURNETTE et al.	1989	Pertussis Toxin SI Mutant with Reduced Enzyme Activity and a Conserved Protective Epitope
FI945110A (fi)	1994-10-31	Tippuribakteerien rokotteiden valmistusmenetelmä

Legal Events

Date	Code	Title	Description
2008-09-08	MK1K	Patent expired